Skip to main content
TipRanks
Go Ultimate75% OFF

Apcotex Industries Ltd (APCOTEXIND) AI Stock Analysis

2 Followers
IN:APCOTEXIND

Apcotex Industries Ltd

(NSE:APCOTEXIND)

Select Model
Rating:81Outperform
Price Target:INR 562.00â–²(15.57% Upside)
Action:upgraded
Date:08/19/26

The score is driven primarily by solid financial strength, featuring a low-leverage balance sheet, recovering earnings, and stronger recent cash generation, alongside a clear positive price trend and supportive momentum indicators. Valuation looks reasonable rather than either cheap or stretched, while the history of margin and cash-flow cyclicality prevents a higher rating.

Positive Factors
Strong Revenue ExpansionRevenue growth of 23.7% demonstrates meaningful expansion across the measured period and supports the company’s ability to scale its specialty-chemicals platform. A larger revenue base can strengthen customer reach, improve operating leverage, and create a durable foundation for future earnings growth.
Negative Factors
Volatile Profit MarginsMargin swings reduce earnings visibility and make it harder to assess the company’s normalized profit potential. The decline in gross margin from earlier highs also suggests that revenue growth has not translated consistently into operating quality, leaving future profitability more sensitive to business-cycle conditions.

Apcotex Industries Ltd (APCOTEXIND) vs. iShares MSCI India ETF (INDA)

-40%-20%0%20%40%60%80%IN:APCOTEXIND+23.67%INDA-5.96%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 25.49B
Dividend Yield
1.65%
Average Volume (3M)
9,526
Price to Earnings (P/E)
14.8
Beta (1Y)
0.59
Revenue Growth
23.74%
EPS Growth
134.63%
Country
India
Employees
616
Sector
General
Sector Strength
55
Industry
Chemicals - Specialty

Apcotex Industries Ltd Business Overview & Revenue Model

Company Description

Headquartered in Mumbai, India, Apcotex Industries Limited is a prominent producer and supplier of synthetic emulsion polymers. Founded in 1980, the company operated as Apcotex Lattices Limited until its rebranding in 2005. Its extensive product rang...

How the Company Makes Money

Apcotex Industries Ltd makes money by manufacturing and selling synthetic rubber and latex products to industrial customers, with revenue primarily driven by: (1) Sale of synthetic rubber (e.g., NBR and SBR): The company produces synthetic rubber gra...

Apcotex Industries Ltd Financial Statement Overview

Summary

Strong revenue growth, low leverage, and much improved recent cash generation, though margins and cash flows have been volatile over time, keeping the score below top tier.

Income Statement

74Positive

Balance Sheet

86Very Positive

Cash Flow

80Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue17.54B14.27B13.92B11.13B10.69B9.51B
Gross Profit4.51B4.30B3.62B3.30B3.56B1.99B
EBITDA2.83B1.94B1.25B1.22B1.66B1.48B
Net Income1.71B1.01B540.65M538.79M1.08B988.06M
Balance Sheet
Total Assets11.63B9.86B9.99B9.22B8.03B6.05B
Cash, Cash Equivalents and Short-Term Investments501.57M684.22M616.38M377.27M302.00M172.71M
Total Debt1.41B963.92M1.89B1.88B1.52B502.64M
Total Liabilities4.50B3.65B4.46B4.00B3.27B2.09B
Stockholders Equity7.13B6.21B5.53B5.22B4.76B3.96B
Cash Flow
Free Cash Flow01.51B347.68M124.39M-656.34M-204.09M
Operating Cash Flow01.95B847.20M402.12M1.21B475.44M
Investing Cash Flow0-602.53M-287.49M-196.35M-1.79B-670.64M
Financing Cash Flow0-1.30B-444.87M-129.89M707.79M119.27M

Apcotex Industries Ltd Technical Analysis

Technical Analysis SentimentNegative
Last Price486.30

Price Trends

50DMA565.05Negative
100DMA570.61Negative
200DMA490.22Negative

Market Momentum

MACD-23.51Negative
RSI32.32Neutral
STOCH35.66Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:APCOTEXIND, the sentiment is Negative. The current price of 486.30 is below the 20-day moving average (MA) of 508.28, below the 50-day MA of 565.05, and below the 200-day MA of 490.22, indicating a bearish trend. The MACD of -23.51 indicates Negative momentum. The RSI at 32.32 is Neutral, neither overbought nor oversold. The STOCH value of 35.66 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:APCOTEXIND.

Apcotex Industries Ltd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:APCOTEXIND against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:APCOTEXINDIN:APCOTEXIND81OutperformINR 25.21B14.79―1.65%23.74%134.63%
IN:ROSSARIIN:ROSSARI65NeutralINR 23.61B15.49―0.12%19.76%11.74%
IN:NOCILIN:NOCIL63NeutralINR 22.97B29.39―1.09%12.29%23.76%
IN:JUBLCPLIN:JUBLCPL61NeutralINR 27.53B26.04――17.18%-15.52%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:TATVAIN:TATVA55NeutralINR 38.76B61.74―0.12%49.69%254.75%
IN:CAMLINFINEIN:CAMLINFINE42NeutralINR 14.42B-178.52――7.92%73.43%

* General Sector Average

Performance Comparison

-50%0%50%IN:APCOTEXINDIN:CAMLINFINEIN:JUBLCPLIN:NOCILIN:ROSSARIIN:TATVADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:APCOTEXIND and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:APCOTEXINDApcotex Industries Ltd486.3097.1624.97%
IN:CAMLINFINECamlin Fine Sciences Limited75.05-81.75-52.14%
IN:JUBLCPLJubilant Agri and Consumer Products Limited1816.95-614.45-25.27%
IN:NOCILNOCIL Limited137.55-32.36-19.05%
IN:ROSSARIRossari Biotech Ltd426.25-195.30-31.42%
IN:TATVATatva Chintan Pharma Chem Limited1656.95124.648.13%

Apcotex Industries Ltd Corporate Events

Apcotex Buys Stake in Solar SPV Amplus Ampere for Captive Power

Oct 31, 2026

Apcotex Industries Ltd has completed the acquisition of 7,20,000 equity shares, representing a 1.275% stake in Amplus Ampere Private Limited, from NRB Bearings Limited for INR 72 lakh in cash. Amplus Ampere, a special purpose vehicle in the power sec...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 30, 2026